BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fehrenbacher N, Philips MR. Targeting RAS - will GPR31 deliver us a new path forward? Mol Cell Oncol 2017;4:e1359228. [PMID: 29209647 DOI: 10.1080/23723556.2017.1359228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Dillon M, Lopez A, Lin E, Sales D, Perets R, Jain P. Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers. Cancers (Basel) 2021;13:5059. [PMID: 34680208 DOI: 10.3390/cancers13205059] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
2 Napolitano M. The role of the 12(S)-HETE/GPR31/12-HETER axis in cancer and ischemia-reperfusion injury. Biochem Soc Trans 2019;47:743-54. [PMID: 30902921 DOI: 10.1042/BST20180635] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]